↓ Skip to main content

The Journal of Rheumatology

Article Metrics

Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study

Overview of attention for article published in Journal of Rheumatology, April 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
5 tweeters

Readers on

mendeley
4 Mendeley
Title
Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study
Published in
Journal of Rheumatology, April 2022
DOI 10.3899/jrheum.210912
Pubmed ID
Authors

Tien Nguyen, Melvin Churchill, Robert Levin, Guillermo Valenzuela, Joseph F. Merola, Alexis Ogdie, Ana-Maria Orbai, Jose U. Scher, Arthur Kavanaugh, Farid Kianifard, Chauncy Rollins, Renato Calheiros, Olivier Chambenoit

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 25%
Lecturer 1 25%
Student > Master 1 25%
Unknown 1 25%
Readers by discipline Count As %
Business, Management and Accounting 1 25%
Computer Science 1 25%
Medicine and Dentistry 1 25%
Unknown 1 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2022.
All research outputs
#1,317,934
of 22,229,192 outputs
Outputs from Journal of Rheumatology
#116
of 3,470 outputs
Outputs of similar age
#28,352
of 343,640 outputs
Outputs of similar age from Journal of Rheumatology
#4
of 47 outputs
Altmetric has tracked 22,229,192 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,470 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,640 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.